Leadless cardiac pacing: What primary care providers and non-EP cardiologists should know

  title={Leadless cardiac pacing: What primary care providers and non-EP cardiologists should know},
  author={Erich L. Kiehl and Daniel J. Cantillon},
  journal={Cleveland Clinic Journal of Medicine},
  pages={S24 - S34}
Over the last 50 years, the use of transvenous pacemakers has been constrained by long-term complications that affect more than 1 in 10 patients, largely attributable to the endovascular leads and surgical pocket. Leadless cardiac pacing involves a self-contained pacemaker deployed directly into the heart without a lead or incisional access. The procedure has shown promise, eliminating pocket-related complications. Other advantages include postprocedural shoulder mobility and the ability to… 

Figures and Tables from this paper

Leadless Pacemaker: Report of the First Experience in Hawai'i.

An understanding of the device design, implantation technique, the advantages and limitations, and the potential of this new pacemaker is provided.

Leadless Pacemaker Implant After Heart Transplant.

The leadless pacemaker: An innovative design to enhance pacemaking capabilities.

Smaller leadless pacemakers placed in the right ventricle can reduce the risk of lead fracture or dislodgement and subcutaneous pocket complications, which can occur with traditional transvenous

The desire for physiological pacing: Are we there yet?

  • G. Kaye
  • Medicine
    Journal of cardiovascular electrophysiology
  • 2019
The background to the development of physiological pacing is reviewed, historical data for right ventricular pacing is evaluated and the basis for change and new lead positions are evaluated.

Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers

CMR imaging in patients with LCP is feasible with excellent to good image quality in the majority of LV segments, however, artefacts in the mid anteroseptal, inferosePTal and apical septal myocardial segments of the LV may impair or even exclude diagnostic evaluation of these segments.

Investigating the influence of the viscoelastic material as a heart muscle simulator on the powering leadless pacemaker from heartbeats by using a piezoelectric beam

This paper studies experimentally and analytically the influence of the viscoelastic cardiac muscle on the energy harvesting from heartbeats for powering the leadless pacemakers by using a



Permanent Leadless Cardiac Pacing: Results of the LEADLESS Trial

In a prospective nonrandomized study, a completely self-contained, single-chamber leadless cardiac pacemaker has shown to be safe and feasible and could represent a paradigm shift in cardiac pacing.

Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study

Early assessment shows the transcatheter pacemaker can safely and effectively be applied and long-term safety and benefit of the pacemaker will further be evaluated in the trial.

Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.

The leadless cardiac pacemaker met prespecified pacing and sensing requirements in the large majority of patients, and met the primary safety end point through 6 months.

Right Ventricular Anatomy Can Accommodate Multiple Micra Transcatheter Pacemakers

The introduction of transcatheter pacemaker technology has the potential to significantly reduce if not eliminate a number of complications associated with a traditional leaded pacing system.

A Leadless Intracardiac Transcatheter Pacing System.

The transcatheter pacemaker implanted in patients who had guideline-based indications for ventricular pacing met the prespecified safety and efficacy goals; it had a safety profile similar to that of a transvenous system while providing low and stable pacing thresholds.

Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial.

Leadless Medtronic Micra pacemaker almost completely endothelialized already after 4 months: first clinical experience from an explanted heart.

A 43-year-old man with congenital heart disease (patent ductus arteriosus and congenital aortic stenosis) underwent leadless pacemaker implantation in September 2016 and his course was complicated by recurrent device-related infections.

Postmortem Histopathological Examination of a Leadless Pacemaker Shows Partial Encapsulation After 19 Months.

An 80-year-old male, with a history of coronary artery disease and bradytachy syndrome, was referred for a recurring pacemaker pocket infection of his dual chamber pacemaker system, and a leadless pacemaker was successfully implanted in the right ventricular apex.

Venous Obstruction After Pacemaker Implantation

Background: Central vein leads are known to predispose to venous obstruction. Although usually asymptomatic, obstruction may render electrode removal difficult. This study aimed at quantifying